Pharmalive - The Pulse of the Pharmaceutical Industry
Search Criteria: Search In:  
Conferences


R&D Directions Insider

Closer peek at Novartis-Alcon potential

Wednesday, January 6th, 2010

Not surprisingly, moods are turning a tad testy in Novartis’ bid to gain full control of Swiss neighbor Alcon Inc. (see reports here and here). But talk of “coercive’’ tactics, minority shareholder protection, and independent director committees aside, just how visionary the potential eye-care deal really is appears a bit ...

Posted in Uncategorized | No Comments »

Progress against swine flu as Novartis begins human tests

Wednesday, August 5th, 2009

As swine flu spreads across 168 countries and territories, another company has begun testing a vaccine in humans. Novartis has begun the company’s first human tests in 6,000 people in a year-long trial in Britain, Germany, and the United States. Last month CSL Ltd., an Australian biopharmaceutical company, became the ...

Posted in H1N1, clinical trials, infectious diseases, vaccines | No Comments »

   
about us | advertise | contact us | home
terms of use | privacy | copyright | site map 		©2010 Canon Communications Pharmaceutical Media Group